Good to see directors buying. Arq has spec upside, and producer solidity. A rare combination that will bear fruit this year with just an ouncxe of exploration luck.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
